+499.5%
MRNA vs RPRX
+77.4%
+422.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RPRX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.1% | -2.4% | -2.5% |
| 7D | +5.5% | +5.1% | +0.4% | -3.7% |
| 30D | +158.7% | +11.2% | +147.5% | +135.5% |
| 3M | +182.1% | +16.7% | +165.4% | +149.5% |
| 6M | +151.8% | +36.0% | +115.8% | +101.1% |
| YTD | +393.6% | +67.8% | +325.8% | +253.2% |
| 1Y | +499.5% | +76.7% | +422.8% | +323.3% |
| All | +499.5% | +77.4% | +422.0% | +323.3% |
Cumulative growth
Daily Returns
Daily percentage return beside RPRX.
Daily Out/Under-Performance
Portfolio return minus RPRX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling